Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority … P Cahn, AL Pozniak, H Mingrone, A Shuldyakov, C Brites, ... The Lancet 382 (9893), 700-708, 2013 | 636 | 2013 |
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1133-1144, 2008 | 571 | 2008 |
EBV MicroRNAs in Primary Lymphomas and Targeting of CXCL-11 by ebv-mir-BHRF1-3 T Xia, A O'Hara, I Araujo, J Barreto, E Carvalho, JB Sapucaia, JC Ramos, ... Cancer research 68 (5), 1436-1442, 2008 | 404 | 2008 |
Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study AR Marra, LFA Camargo, ACC Pignatari, T Sukiennik, PRP Behar, ... Journal of clinical microbiology 49 (5), 1866-1871, 2011 | 390 | 2011 |
Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV … Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1145-1155, 2008 | 260 | 2008 |
High Zika virus seroprevalence in Salvador, northeastern Brazil limits the potential for further outbreaks EM Netto, A Moreira-Soto, C Pedroso, C Höser, S Funk, AJ Kucharski, ... MBio 8 (6), 10.1128/mbio. 01390-17, 2017 | 233 | 2017 |
Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has … M Aboud, R Kaplan, J Lombaard, F Zhang, JA Hidalgo, E Mamedova, ... The Lancet infectious diseases 19 (3), 253-264, 2019 | 185 | 2019 |
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial SMART Study Group* Annals of internal medicine 149 (5), 289-299, 2008 | 173 | 2008 |
High prevalence of giardiasis and strongyloidiasis among HIV-infected patients in Bahia, Brazil G Feitosa, AC Bandeira, DP Sampaio, R Badaró, C Brites Brazilian Journal of Infectious Diseases 5, 339-344, 2001 | 150 | 2001 |
Severe and Norwegian scabies are strongly associated with retroviral (HIV-1/HTLV-1) infection in Bahia, Brazil C Brites, M Weyll, C Pedroso, R Badaró Aids 16 (9), 1292-1293, 2002 | 138 | 2002 |
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial B Grinsztejn, N De Castro, V Arnold, VG Veloso, M Morgado, JH Pilotto, ... The Lancet infectious diseases 14 (6), 459-467, 2014 | 137 | 2014 |
Saliva is a reliable, non-invasive specimen for SARS-CoV-2 detection SN Vaz, DS Santana, EM Netto, C Pedroso, WK Wang, FDA Santos, ... Brazilian Journal of Infectious Diseases 24 (5), 422-427, 2020 | 130 | 2020 |
Adult T-cell leukemia/lymphoma in Bahia, Brazil: analysis of prognostic factors in a group of 70 patients AL Bittencourt, MG Vieira, CR Brites, L Farre, HS Barbosa American journal of clinical pathology 128 (5), 875-882, 2007 | 130 | 2007 |
Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5′ long terminal repeat domain C Drosten, M Panning, JF Drexler, F Hansel, C Pedroso, J Yeats, ... Clinical chemistry 52 (7), 1258-1266, 2006 | 126 | 2006 |
Efficacy and safety of switching to the 2-drug regimen dolutegravir/lamivudine versus continuing a 3-or 4-drug regimen for maintaining virologic suppression in adults living … JM Llibre, C Brites, CY Cheng, O Osiyemi, C Galera, L Hocqueloux, ... Clinical Infectious Diseases 76 (4), 720-729, 2023 | 123 | 2023 |
Infective dermatitis and human T cell lymphotropic virus type 1–associated myelopathy/tropical spastic paraparesis in childhood and adolescence JRL Primo, C Brites, MFSP de Oliveira, O Moreno-Carvalho, M Machado, ... Clinical infectious diseases 41 (4), 535-541, 2005 | 122 | 2005 |
Quality of life, anxiety and depression in patients with HIV/AIDS who present poor adherence to antiretroviral therapy: a cross-sectional study in Salvador, Brazil MN Betancur, L Lins, IR Oliveira, C Brites Brazilian Journal of Infectious Diseases 21, 507-514, 2017 | 119 | 2017 |
HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression C Brites, J Sampalo, A Oliveira AIDS Rev 11 (1), 8-16, 2009 | 119 | 2009 |
A systematic review on physical function, activities of daily living and health-related quality of life in COVID-19 survivors K de Oliveira Almeida, IG Nogueira Alves, RS de Queiroz, MR de Castro, ... Chronic illness 19 (2), 279-303, 2023 | 110 | 2023 |
Nosocomial bloodstream infections in Brazilian pediatric patients: microbiology, epidemiology, and clinical features CAP Pereira, AR Marra, LFA Camargo, ACC Pignatari, T Sukiennik, ... PloS one 8 (7), e68144, 2013 | 108 | 2013 |